nitroglycerin has been researched along with Angiogenesis, Pathologic in 3 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Knobloch, K | 1 |
Thermann, H | 1 |
Maeda, H | 1 |
Hautamaa, PV | 1 |
Dai, XZ | 1 |
Homans, DC | 1 |
Bache, RJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
TENDOSHOCK-2010 - Combined Sclerosing Therapy, Extracorporeal Shockwave Therapy, Eccentric Training and Topical Glyceryl Trinitrate for Athletic Tendinopathies[NCT01185951] | Phase 2 | 114 participants (Actual) | Interventional | 2007-01-31 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 other studies available for nitroglycerin and Angiogenesis, Pathologic
Article | Year |
---|---|
[Achilles tendinopathy--modern evidence-based recommendations].
Topics: Achilles Tendon; Administration, Topical; Bandages; Diagnosis, Differential; Humans; Neovascularizat | 2008 |
Nitroglycerin enhances vascular blood flow and drug delivery in hypoxic tumor tissues: analogy between angina pectoris and solid tumors and enhancement of the EPR effect.
Topics: Angina Pectoris; Animals; Antineoplastic Agents; Blood Flow Velocity; Contrast Media; Coronary Circu | 2010 |
Vasomotor activity of moderately well-developed canine coronary collateral circulation.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Azepines; Coronary Circulation; Coronary Vessels | 1989 |